$DCGO News

Needham Reiterates Buy on DocGo, Maintains $3 Price Target

DocGo Inc. (DCGO) Discusses Pending Acquisition of Hicuity Health and Related Financial Projections Transcript

DocGo Inc. (DCGO) Discusses Pending Acquisition of Hicuity Health and Related Financial Projections - Slideshow

DocGo Announces Upcoming Webinar to Outline Vision and Details of the Pending Hicuity Health Acquisition

DocGo Inc. (DCGO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

DocGo Inc (DCGO) (Q2 2026) Earnings Call Highlights: Record Volumes and Strategic Hicuity ...

DocGo Inc. Q2 2026 Earnings Call Summary

DocGo Shares Tumble After Earnings Miss and Wider Loss Forecast

Needham Reiterates Buy on DocGo, Maintains $3 Price Target

DocGo Q2 Earnings Call Highlights

DocGo Inc. (DCGO) Surpasses Q2 Earnings Estimates

DocGo Announces Second Quarter 2026 Results

DocGo Inc. (DCGO) Q2 2026 Earnings Call Transcript

Transcript: DocGo Q2 2026 Earnings Conference Call

DocGo Signs Agreement To Acquire Hicuity Health; Hicuity Health Shareholders To Get 2% Of DocGo's Common Shares

DocGo Narrows FY2026 Sales Guidance from $300.000M-$315.000M to $305.000M-$310.000M vs $306.281M Est

DocGo Q2 EPS $(0.16) Misses $(0.06) Estimate, Sales $73.425M Miss $75.404M Estimate

DocGo Likely To Report Narrower Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

DocGo to Announce Second Quarter 2026 Results on Monday, August 17, 2026

DocGo Granted Additional 180-Day Nasdaq Extension Through Jan. 25, 2027 To Regain Compliance